diagnost tool
medic aesthet issu rear view
mirror reiter hold trim pt
trim pt announc close today
expect cynosur revenu come prior expect
expect achiev low end adj ep guid
indic file close today revenu shortfal
medic aesthet busi quarter result lost sale tempsur vitalia
part due refund rebat paid custom previous purchas vitalia
tempsur instrument refund rebat record reduct revenu
addit indic also see lighter revenu monalisa touch
updat model time print adj ep
think may still achiev continu model revenu
y/i vs compani reiter revenu guidanc
disappoint updat surpris unfortun think
take longer manag return busi healthi growth
think timelin growth rate exactli clear begin
primari hangup relat cultur drove ultra-strong growth
old cynosur versu today cultur present materi differ
view know normal pro-forma growth rate new
cynosur busi particularli compet formid player
allergan acquir zeltiq look updat allergan host
analyst day medic aesthet busi come friday septemb
et includ updat pipelin
posit note encourag expect make lost
medic aesthet revenu stronger-than-expect oper outsid medic
aesthet think like breast health diagnost continu
realli like industry-lead expand breast health diagnost
portfolio believ would stock even higher compani
cynosur possess reiter hold rate look
attract entri point stock price target appli multipl
adj ep estim share nearli ytd
averag compani return coverag ytd expect provid
guidanc upcom earn call time expect
initi estim
price close busi septemb
global leader diagnost breast
imag surgic product focu women
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ object view
compani secur subject report discuss herein
import inform pleas see import disclosur begin page document
compani report canaccord genuiti estim detail financi model includ balanc sheet incom statement cash flow project avail may obtain contact canaccord genuiti sale person author analyst whose contact
inform appear front page report
hold unchang target price septemb
diagnost tool
hold unchang target price septemb
diagnost tool
